Lake Street analyst Brooks O’Neil notes that Stryker (SYK) announced a definitive agreement for the sale of its U.S. spinal implants business ...

Stryker Corp (SYK) reports over 10% organic sales growth and outlines strategic acquisitions amidst challenges in its Q4 2024 ...

On Jan. 28, Stryker Corp. announced plans to sell its U.S. spinal implant business to investment firm Viscogliosi Brothers. Though Stryker has a major share in the U.S. spine and orthopedic market, ...

Stryker (NYSE:SYK – Get Free Report) had its target price hoisted by investment analysts at Stifel Nicolaus from $400.00 to ...

Stryker (NYSE:SYK – Get Free Report) had its price target raised by research analysts at Canaccord Genuity Group from $420.00 ...

Beeline Labs, a new division of Eastside Distilling, launches BlinkQC, a QC solution for lenders that automates the process in 3 mins, saving time and money.

Stryker (NYSE:SYK) reported operating results for the fourth quarter and full year of 2024: Fourth Quarter Results Reported net sales increased 10.7% ...

FY25 Outlook: Sirius XM expects revenue of $8.500 billion versus the consensus of $8.594 billion. It also projected an adjusted EBITDA of $2.60 billion and expects a free cash flow of $1.15 billion.

The Shareholders' Nomination Board of Bioretec Ltd ("Bioretec") has resolved to make the following proposals to the Annual General Meeting. The Annual General Meeting of Bioretec is scheduled to be ...

Notably, Stryker was named the most admired medtech company in the world. Another major orthopedic and spine device manufacturer, Medtronic, also earned a spot. 1. Stryker Corp.

Truist raised the firm’s price target on Stryker (SYK) to $413 from $409 and keeps a Hold rating on the shares. The company remains a top-tier ...

Private equity returns overtook those offered by private credit in the third quarter, according to data from State Street Corp., in what some see as a sign of a longer-term rebalancing between the two ...